N-Methyl-4-(Methylamino)Benzene-1-Sulfonamide(WX602083)
|
- $240 - $1443
- Product name: N-Methyl-4-(Methylamino)Benzene-1-Sulfonamide(WX602083)
- CAS: 137473-37-1
- MF: C8H12N2O2S
- MW: 200.26
- EINECS:
- MDL Number:MFCD11207375
- Synonyms:N-Methyl-4-(Methylamino)Benzene-1-Sulfonamide(WX602083);N-METHYL-4-(METHYLAMINO)BENZENE-1-SULFONAMIDE;N-methyl-4-(methylamino)benzenesulfonamide;Benzenesulfonamide, N-methyl-4-(methylamino)-
4 prices
Selected condition：
Brand
- Alichem
- Crysdot
- TRC
Package
- 100mg
- 1g
- 5g
- ManufacturerAlichem
- Product number137473371
- Product descriptionN-Methyl-4-(methylamino)benzene-1-sulfonamide
- Packaging5g
- Price$1443
- Updated2021-12-16
- Buy
- ManufacturerAlichem
- Product number137473371
- Product descriptionN-Methyl-4-(methylamino)benzene-1-sulfonamide
- Packaging1g
- Price$500.24
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12147643
- Product descriptionN-Methyl-4-(methylamino)benzenesulfonamide 95+%
- Packaging1g
- Price$667
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberM354623
- Product descriptionN-Methyl-4-(methylamino)benzene-1-sulfonamide
- Packaging100mg
- Price$240
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Alichem | 137473371 | N-Methyl-4-(methylamino)benzene-1-sulfonamide | 5g | $1443 | 2021-12-16 | Buy |
| Alichem | 137473371 | N-Methyl-4-(methylamino)benzene-1-sulfonamide | 1g | $500.24 | 2021-12-16 | Buy |
| Crysdot | CD12147643 | N-Methyl-4-(methylamino)benzenesulfonamide 95+% | 1g | $667 | 2021-12-16 | Buy |
| TRC | M354623 | N-Methyl-4-(methylamino)benzene-1-sulfonamide | 100mg | $240 | 2021-12-16 | Buy |
Properties
Boiling point :350.1±44.0 °C(Predicted)
Density :1?+-.0.06 g/cm3(Predicted)
pka :12.44±0.30(Predicted)
Density :1?+-.0.06 g/cm3(Predicted)
pka :12.44±0.30(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|